Rudolf Armin Manz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rudolf Armin Manz has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
- Marc Ehlers
Laboratory of Immunology, Institute of Nutritional Medicine, University of Luebeck and University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
7 shared publications - Ralf Joachim Ludwig
Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany
5 shared publications Upasana Kulkarni
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States
5 shared publicationsAnn-Katrin Clauder
Universitat zu Lubeck Institut fur Systemische Entzundungsforschung
4 shared publicationsBenjamin Tiburzy
Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany
4 shared publicationsFred D. Finkelman
University of Cincinnati Division of Rheumatology Allergy and Immunology
4 shared publications
Latest Publications
- Open Access
- 12 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 1590
Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn’s disease
Secretory IgA (SIgA) is critical for maintaining the intestinal barrier. A dysregulated B-cell compartment and altered Ig secretion have been well documented in Crohn’s disease (CD) patients, although their origin is unknown. To unravel the role of mucosal humoral immunity in CD pathogenesis, we in-depth phenotype colonic plasma cell (PC) differentiation in CD at the single-cell level, linked to ex vivo functional characterization and experimental mouse models with a congenital mitochondrial defect or under glucose-free high-protein dietary intervention. Here, we demonstrate that despite expanded colonic B cells, CD patients in remission present significantly diminished mucosal dimeric IgA and fecal SIgA. Colonic plasmablasts and immature CD19 + CD45 + PCs are increased at the expense of the mature CD19 - CD45 - phenotype. Accordingly, CD-derived ex vivo differentiated PCs display impaired maturation into dimeric IgA-secreting PCs. In this study, patient-derived data from colonic RNA-seq, spatial single-cell proteomics, and plasma metabolomics are combined with data from both mouse models and highlight the crucial role of mitochondrial oxidative phosphorylation in colonic IgA + -PC differentiation, suggesting promising directions for future therapeutic strategies.
- 12 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 1590
Open AccessColonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn’s disease
Secretory IgA (SIgA) is critical for maintaining the intestinal barrier. A dysregulated B-cell compartment and altered Ig secretion have been well documented in Crohn’s disease (CD) patients, although their origin is unknown. To unravel the role of mucosal humoral immunity in CD pathogenesis, we in-depth phenotype colonic plasma cell (PC) differentiation in CD at the single-cell level, linked to ex vivo functional characterization and experimental mouse models with a congenital mitochondrial defect or under glucose-free high-protein dietary intervention. Here, we demonstrate that despite expanded colonic B cells, CD patients in remission present significantly diminished mucosal dimeric IgA and fecal SIgA. Colonic plasmablasts and immature CD19 + CD45 + PCs are increased at the expense of the mature CD19 - CD45 - phenotype. Accordingly, CD-derived ex vivo differentiated PCs display impaired maturation into dimeric IgA-secreting PCs. In this study, patient-derived data from colonic RNA-seq, spatial single-cell proteomics, and plasma metabolomics are combined with data from both mouse models and highlight the crucial role of mitochondrial oxidative phosphorylation in colonic IgA + -PC differentiation, suggesting promising directions for future therapeutic strategies.
- Open Access
Allergic Sensitization to Inhalant Allergens in the Upper Respiratory Tract—the B Cell Side
Allergic diseases are on the rise worldwide, driven by respiratory epithelial barrier dysfunction that promotes sensitization to inhalant allergens such as pollen, dust mites, pet dander, and fungal spores. These antigens trigger IgE‐mediated immune responses that lead to diseases such as allergic rhinitis (AR) and asthma. B cells play a central role by producing allergen‐specific IgE, presenting antigens, releasing cytokines, and forming memory B cells (MBCs). Their differentiation into IgE‐secreting plasma cells (PCs) mainly relies on T cell help, germinal center (GC) reactions, and/or extrafollicular responses and class switch recombination (CSR), which makes them important therapeutic targets. The nasal mucosa, as the first point of contact for allergens, acts both as a barrier and as an immunological site. In AR, IL‐13‐driven goblet cell hyperplasia and overproduction of mucus compromise the integrity of the barrier. Although the nasal microbiome can influence the immune response, its role in atopy remains unclear. Local B cell activity, including extrafollicular IgE production and ectopic GCs, enhances mucosal immunity. Epithelial cells detect allergens via pattern recognition receptors (PRRs) and release alarmins (IL‐25, IL‐33, TSLP), which can trigger type 2 inflammation. Proteases from allergens such as house dust mites (HDM) disrupt epithelial junctions, while pollutants, smoke, microplastics, and allergen‐derived metabolites further modulate immune activation. Allergens are transported to the lymph nodes by the passive flow to follicular dendritic cells (FDCs) or by active uptake by interferon regulatory factor (IRF) 4‐dependent conventional type 2 DCs, which activate T follicular helper (TFH) cells to drive IgE responses. Advanced lymphoid organoids that mimic the microenvironment of GCs offer promising models for the study of allergic sensitization but require improved standardization.
Open AccessAllergic Sensitization to Inhalant Allergens in the Upper Respiratory Tract—the B Cell Side
Allergic diseases are on the rise worldwide, driven by respiratory epithelial barrier dysfunction that promotes sensitization to inhalant allergens such as pollen, dust mites, pet dander, and fungal spores. These antigens trigger IgE‐mediated immune responses that lead to diseases such as allergic rhinitis (AR) and asthma. B cells play a central role by producing allergen‐specific IgE, presenting antigens, releasing cytokines, and forming memory B cells (MBCs). Their differentiation into IgE‐secreting plasma cells (PCs) mainly relies on T cell help, germinal center (GC) reactions, and/or extrafollicular responses and class switch recombination (CSR), which makes them important therapeutic targets. The nasal mucosa, as the first point of contact for allergens, acts both as a barrier and as an immunological site. In AR, IL‐13‐driven goblet cell hyperplasia and overproduction of mucus compromise the integrity of the barrier. Although the nasal microbiome can influence the immune response, its role in atopy remains unclear. Local B cell activity, including extrafollicular IgE production and ectopic GCs, enhances mucosal immunity. Epithelial cells detect allergens via pattern recognition receptors (PRRs) and release alarmins (IL‐25, IL‐33, TSLP), which can trigger type 2 inflammation. Proteases from allergens such as house dust mites (HDM) disrupt epithelial junctions, while pollutants, smoke, microplastics, and allergen‐derived metabolites further modulate immune activation. Allergens are transported to the lymph nodes by the passive flow to follicular dendritic cells (FDCs) or by active uptake by interferon regulatory factor (IRF) 4‐dependent conventional type 2 DCs, which activate T follicular helper (TFH) cells to drive IgE responses. Advanced lymphoid organoids that mimic the microenvironment of GCs offer promising models for the study of allergic sensitization but require improved standardization.
- Open Access
- 13 August 2025
- Published by Wiley
Divergent IgE to IgG hypermutation is associated with allergic hypothermia in mice
Background: Immunoglobulin (Ig)E can mediate food allergy and anaphylaxis, which can be inhibited by clonally related IgG. It is unclear whether differential hypermutation of clonally related IgE and IgG limits IgG suppression of IgE-mediated disease. Methods: A murine model of hen’s egg allergy with the major allergens ovalbumin (OVA) and ovomucoid (OVO) was employed to investigate allergen-induced induced anaphylaxis (detected as hypothermia). Deep sequencing of IgE and IgG1 was used to identify IgE clones with divergent hypermutation profiles compared to their clonally related IgG progenitors. Binding to OVA and OVO was predicted by in silico analysis. IgG-mediated blockade of IgE binding to OVA and OVO was tested by ELISA. Results: A small subset of IgE clones acquired somatic CDR3 hypermutations that were absent in their clonally related IgG1 progenitors, these clones were called ”divergent” IgE. The presence and clonal expansion of highly mutated divergent IgE clonotypes correlated with the development of allergen-induced severe hypothermia. In contrast and independent of their hypermutation rate, the presence of other IgE clones did not correlate with allergic hypothermia. Predictive analysis suggests that the relevant divergent IgE clonotypes predominantly reacted to OVO rather than OVA. Serum IgG from allergic mice could block binding of OVA-specific but not OVO-specific IgE. Divergent IgE was also observed in the bone marrow (BM) of allergic patients. Conclusion: This study identifies a small subset of highly hypermutated “divergent IgE clonotypes” associated with severe anaphylaxis and provides a possible mechanism by which allergy-promoting IgE escape from competition by IgG progenitor clones.
- 13 August 2025
- Published by Wiley
Open AccessDivergent IgE to IgG hypermutation is associated with allergic hypothermia in mice
Background: Immunoglobulin (Ig)E can mediate food allergy and anaphylaxis, which can be inhibited by clonally related IgG. It is unclear whether differential hypermutation of clonally related IgE and IgG limits IgG suppression of IgE-mediated disease. Methods: A murine model of hen’s egg allergy with the major allergens ovalbumin (OVA) and ovomucoid (OVO) was employed to investigate allergen-induced induced anaphylaxis (detected as hypothermia). Deep sequencing of IgE and IgG1 was used to identify IgE clones with divergent hypermutation profiles compared to their clonally related IgG progenitors. Binding to OVA and OVO was predicted by in silico analysis. IgG-mediated blockade of IgE binding to OVA and OVO was tested by ELISA. Results: A small subset of IgE clones acquired somatic CDR3 hypermutations that were absent in their clonally related IgG1 progenitors, these clones were called ”divergent” IgE. The presence and clonal expansion of highly mutated divergent IgE clonotypes correlated with the development of allergen-induced severe hypothermia. In contrast and independent of their hypermutation rate, the presence of other IgE clones did not correlate with allergic hypothermia. Predictive analysis suggests that the relevant divergent IgE clonotypes predominantly reacted to OVO rather than OVA. Serum IgG from allergic mice could block binding of OVA-specific but not OVO-specific IgE. Divergent IgE was also observed in the bone marrow (BM) of allergic patients. Conclusion: This study identifies a small subset of highly hypermutated “divergent IgE clonotypes” associated with severe anaphylaxis and provides a possible mechanism by which allergy-promoting IgE escape from competition by IgG progenitor clones.
- Open Access
- 23 April 2025
- Published by Springer Nature in Research Square
Mucosal deficiency of mitochondria-driven humoral immunity is linked to Crohn’s Disease
Secretory IgA (SIgA) is critical for maintaining the intestinal barrier. A dysregulated B-cell compartment and altered Ig secretion have been well documented in Crohn’s disease (CD) patients, although their origin is unknown. To unravel the role of mucosal humoral immunity in CD pathogenesis, we in-depth phenotyped colonic plasma cell (PC) differentiation in CD at the single-cell level, linked to ex vivo functional characterization and experimental mouse models. Despite expanded colonic B cells, CD patients in remission presented significantly diminished mucosal dimeric IgA and fecal SIgA. Colonic plasmablasts and immature CD19 + CD45 + PCs were increased at the expense of the mature CD19 - CD45 - phenotype. Accordingly, CD-derived ex vivo differentiated PCs displayed impaired maturation into IgA-secreting PCs. Patient-derived data from colonic RNA-seq, spatial single-cell proteomics, and NMR-metabolomics were combined with data from two mouse models and highlighted the crucial role of mitochondria function in colonic IgA + -PC differentiation, suggesting promising directions for future therapeutic strategies.
- 23 April 2025
- Published by Springer Nature in Research Square
Open AccessMucosal deficiency of mitochondria-driven humoral immunity is linked to Crohn’s Disease
Secretory IgA (SIgA) is critical for maintaining the intestinal barrier. A dysregulated B-cell compartment and altered Ig secretion have been well documented in Crohn’s disease (CD) patients, although their origin is unknown. To unravel the role of mucosal humoral immunity in CD pathogenesis, we in-depth phenotyped colonic plasma cell (PC) differentiation in CD at the single-cell level, linked to ex vivo functional characterization and experimental mouse models. Despite expanded colonic B cells, CD patients in remission presented significantly diminished mucosal dimeric IgA and fecal SIgA. Colonic plasmablasts and immature CD19 + CD45 + PCs were increased at the expense of the mature CD19 - CD45 - phenotype. Accordingly, CD-derived ex vivo differentiated PCs displayed impaired maturation into IgA-secreting PCs. Patient-derived data from colonic RNA-seq, spatial single-cell proteomics, and NMR-metabolomics were combined with data from two mouse models and highlighted the crucial role of mitochondria function in colonic IgA + -PC differentiation, suggesting promising directions for future therapeutic strategies.
- Open Access
- 8 December 2023
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 8 (1) , 1-2
IgE-Mast cell mediated allergy: a sensor of food quality
- 8 December 2023
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 8 (1) , 1-2
Open AccessIgE-Mast cell mediated allergy: a sensor of food quality
- Open Access
The B Cell Response and Formation of Allergenic and Anti-Allergenic Antibodies in Food Allergy
Food allergies are a growing public health concern worldwide, especially in children and young adults. Allergen-specific IgE plays a central role in the pathogenesis of food allergies, but their titers poorly correlate with allergy development. Host immune systems yield allergen-specific immunoglobulin (Ig)A, IgE and IgG subclasses with low or high affinities and differential Fc N-glycosylation patterns that can affect the allergic reaction to food in multiple ways. High-affinity IgE is required to induce strong mast cell activation eventually leading to allergic anaphylaxis, while low-affinity IgE can even inhibit the development of clinically relevant allergic symptoms. IgA and IgG antibodies can inhibit IgE-mediated mast cell activation through various mechanisms, thereby protecting IgE-positive individuals from allergy development. The production of IgE and IgG with differential allergenic potential seems to be affected by the signaling strength of individual B cell receptors, and by cytokines from T cells. This review provides an overview of the diversity of the B cell response and the diverse roles of antibodies in food allergy.
Open AccessThe B Cell Response and Formation of Allergenic and Anti-Allergenic Antibodies in Food Allergy
Food allergies are a growing public health concern worldwide, especially in children and young adults. Allergen-specific IgE plays a central role in the pathogenesis of food allergies, but their titers poorly correlate with allergy development. Host immune systems yield allergen-specific immunoglobulin (Ig)A, IgE and IgG subclasses with low or high affinities and differential Fc N-glycosylation patterns that can affect the allergic reaction to food in multiple ways. High-affinity IgE is required to induce strong mast cell activation eventually leading to allergic anaphylaxis, while low-affinity IgE can even inhibit the development of clinically relevant allergic symptoms. IgA and IgG antibodies can inhibit IgE-mediated mast cell activation through various mechanisms, thereby protecting IgE-positive individuals from allergy development. The production of IgE and IgG with differential allergenic potential seems to be affected by the signaling strength of individual B cell receptors, and by cytokines from T cells. This review provides an overview of the diversity of the B cell response and the diverse roles of antibodies in food allergy.
- Open Access
- 4 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Tissue-resident B cells orchestrate macrophage polarisation and function
B cells play a central role in humoral immunity but also have antibody-independent functions. Studies to date have focused on B cells in blood and secondary lymphoid organs but whether B cells reside in non-lymphoid organs (NLO) in homeostasis is unknown. Here we identify, using intravenous labeling and parabiosis, a bona-fide tissue-resident B cell population in lung, liver, kidney and urinary bladder, a substantial proportion of which are B-1a cells. Tissue-resident B cells are present in neonatal tissues and also in germ-free mice NLOs, albeit in lower numbers than in specific pathogen-free mice and following co-housing with ‘pet-store’ mice. They spatially co-localise with macrophages and regulate their polarization and function, promoting an anti-inflammatory phenotype, in-part via interleukin-10 production, with effects on bacterial clearance during urinary tract infection. Thus, our data reveal a critical role for tissue-resident B cells in determining the homeostatic ‘inflammatory set-point’ of myeloid cells, with important consequences for tissue immunity.
- 4 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Open AccessTissue-resident B cells orchestrate macrophage polarisation and function
B cells play a central role in humoral immunity but also have antibody-independent functions. Studies to date have focused on B cells in blood and secondary lymphoid organs but whether B cells reside in non-lymphoid organs (NLO) in homeostasis is unknown. Here we identify, using intravenous labeling and parabiosis, a bona-fide tissue-resident B cell population in lung, liver, kidney and urinary bladder, a substantial proportion of which are B-1a cells. Tissue-resident B cells are present in neonatal tissues and also in germ-free mice NLOs, albeit in lower numbers than in specific pathogen-free mice and following co-housing with ‘pet-store’ mice. They spatially co-localise with macrophages and regulate their polarization and function, promoting an anti-inflammatory phenotype, in-part via interleukin-10 production, with effects on bacterial clearance during urinary tract infection. Thus, our data reveal a critical role for tissue-resident B cells in determining the homeostatic ‘inflammatory set-point’ of myeloid cells, with important consequences for tissue immunity.
- Open Access
- 11 October 2023
- Published by MDPI AG in Preprints.org
The B Cell Response and Formation of Allergenic and Anti-allergenic Antibodies in Food Allergy
Food allergies are a growing public health concern worldwide, especially in children and young adults. Allergen-specific IgE plays a central role in the pathogenesis of food allergies, but their titers poorly correlate with allergy development. Host immune systems yield allergen-specific immunoglobulin (Ig)A, IgE and IgG subclasses with low or high affinities and differential Fc N-glycosylation patterns that can affect the allergic reaction to food in multiple ways. High affinity IgE is required to induce strong mast cell activation eventually leading to allergic anaphylaxis while low affinity IgE can even inhibit the development of clinically relevant allergic symptoms. IgA and IgG antibodies can inhibit IgE-mediated mast cell activation through various mechanisms, thereby protecting IgE-positive individuals from allergy development. The production of IgE and IgG with differential allergenic potential seems to be affected by the signaling strength of individual B cell receptors, and by cytokines from T cells. This review provides an overview of the diversity of the B cell response and the diverse roles of antibodies in food allergy.
- 11 October 2023
- Published by MDPI AG in Preprints.org
Open AccessThe B Cell Response and Formation of Allergenic and Anti-allergenic Antibodies in Food Allergy
Food allergies are a growing public health concern worldwide, especially in children and young adults. Allergen-specific IgE plays a central role in the pathogenesis of food allergies, but their titers poorly correlate with allergy development. Host immune systems yield allergen-specific immunoglobulin (Ig)A, IgE and IgG subclasses with low or high affinities and differential Fc N-glycosylation patterns that can affect the allergic reaction to food in multiple ways. High affinity IgE is required to induce strong mast cell activation eventually leading to allergic anaphylaxis while low affinity IgE can even inhibit the development of clinically relevant allergic symptoms. IgA and IgG antibodies can inhibit IgE-mediated mast cell activation through various mechanisms, thereby protecting IgE-positive individuals from allergy development. The production of IgE and IgG with differential allergenic potential seems to be affected by the signaling strength of individual B cell receptors, and by cytokines from T cells. This review provides an overview of the diversity of the B cell response and the diverse roles of antibodies in food allergy.
- Open Access
- 16 September 2022
- Published by Elsevier in Mucosal Immunology
- Vol. 15 (6) , 1375-1388
B-cell receptor physical properties affect relative IgG1 and IgE responses in mouse egg allergy
- 16 September 2022
- Published by Elsevier in Mucosal Immunology
- Vol. 15 (6) , 1375-1388
Open AccessB-cell receptor physical properties affect relative IgG1 and IgE responses in mouse egg allergy
- Open Access
- 22 October 2021
- Published by Wiley in European Journal of Immunology
- Vol. 52 (2) , 197-203
MHC haplotype and B cell autoimmunity: Correlation with pathogenic IgG autoantibody subclasses and Fc glycosylation patterns
Genome-wide association studies (GWAS) have identified many genes that are associated with the development of certain autoimmune disorders, but the MHC haplotypes still represent the most prevalent genetic risk factor for many autoimmune diseases. The mechanisms by which MHC-associated genetic susceptibility translates into B cell autoimmunity and the development of autoimmune diseases are complex. There is increasing evidence that the MHC haplotype modulates autoreactive B cell responses in multiple ways. Instead of merely inhibiting the production of IgG autoantibodies and mediating complete immunological tolerance, the non-permitting MHC haplotypes seem to facilitate the production of IgG autoantibodies exhibiting Fc glycosylation patterns that are associated with reduced pathogenicity and a protective cytokine profile of T follicular helper (Tfh) cells. Here, we discuss mechanisms linking MHC haplotypes to the production of pathogenic IgG autoantibodies, which could be relevant for the development of improved diagnosis, particularly in the context of individual medicine.
- 22 October 2021
- Published by Wiley in European Journal of Immunology
- Vol. 52 (2) , 197-203
Open AccessMHC haplotype and B cell autoimmunity: Correlation with pathogenic IgG autoantibody subclasses and Fc glycosylation patterns
Genome-wide association studies (GWAS) have identified many genes that are associated with the development of certain autoimmune disorders, but the MHC haplotypes still represent the most prevalent genetic risk factor for many autoimmune diseases. The mechanisms by which MHC-associated genetic susceptibility translates into B cell autoimmunity and the development of autoimmune diseases are complex. There is increasing evidence that the MHC haplotype modulates autoreactive B cell responses in multiple ways. Instead of merely inhibiting the production of IgG autoantibodies and mediating complete immunological tolerance, the non-permitting MHC haplotypes seem to facilitate the production of IgG autoantibodies exhibiting Fc glycosylation patterns that are associated with reduced pathogenicity and a protective cytokine profile of T follicular helper (Tfh) cells. Here, we discuss mechanisms linking MHC haplotypes to the production of pathogenic IgG autoantibodies, which could be relevant for the development of improved diagnosis, particularly in the context of individual medicine.